gadolinium has been researched along with Red-Cell Aplasia, Pure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, CL; Bookstaver, PB; Cournoyer, D; Cowper, S; Kahn, A; Locatelli, F; Lopez, I; Luminari, S; Macdougall, IC; Mattison, DR; Miller, AD; Murday, A; Norris, LB; Qureshi, ZP; Ray, P; Sartor, O; Starko, KM; Thomsen, HS; Trenery, A; Xirasagar, S | 1 |
1 review(s) available for gadolinium and Red-Cell Aplasia, Pure
Article | Year |
---|---|
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).
Topics: Aspirin; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Female; Gadolinium; Humans; Male; Nephrogenic Fibrosing Dermopathy; Prevalence; Prognosis; Red-Cell Aplasia, Pure; Reye Syndrome; Risk Assessment; South Carolina; Survival Rate | 2012 |